Astellas Pharma Inc Unsponsored ADR Stock Performance
as on July 3, 2026 at 6:58 am IST
Day's Low
Day's High
$13.23$13.41
0.45%
Downside
0.90%
Upside
52 Week's Low
52 Week's High
100.00%
Downside
-100.00%
Upside
Astellas Pharma Inc Unsponsored ADR share price movements today
- Previous Close
- $13.04
- Open
- $13.26
- Volume
- 396.6K
- Day's Low - High
- $13.23 - $13.41
Astellas Pharma Inc Unsponsored ADR Historical Returns
- 1 Month Return
- 0 %
- 3 Month Return
- 0 %
- 1 Year Return
- 0 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Astellas Pharma Inc Unsponsored ADR Stock Fundamentals & Key Indicators
Check Astellas Pharma Inc Unsponsored ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$23.4B
EPS (TTM)
0.9535
Dividend Yield
3.80%
PE Ratio (TTM)
13.04
Industry PE ratio
12.096666666666668
PEG Ratio
0Return On Equity TTM
17.44%
Astellas Pharma Inc Unsponsored ADR Stock Valuation
Track how Astellas Pharma Inc Unsponsored ADR P/E has moved over time to understand its valuation trends.
Astellas Pharma Inc Unsponsored ADR in the last 5 years
Lowest (-50.36x)
December 31, 2024
Industry (12.10x)
July 3, 2026
Today (13.04x)
July 3, 2026
Highest (161.71x)
March 31, 2024
Today’s Price to Earnings Ratio: 13.04x
Astellas Pharma Inc Unsponsored ADR vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Astellas Pharma Inc Unsponsored ADR with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| NA | $23.4B | NA | 13.04 | 13.63% | 3.8% | |
| BUY | $300.8B | 221.02% | 29.21 | 17.19% | 1.7399999999999998% | |
| BUY | $1.1T | 418.85% | 42.37 | 34.99% | 0.52% | |
| BUY | $443.6B | 126.68% | 123.67 | 5.79% | 2.68% | |
| BUY | $611.4B | 55.66% | 29.4 | 21.83% | 2.0500000000000003% |
Astellas Pharma Inc Unsponsored ADR Quarterly Profit & Loss
All numbers in Millions USD
Astellas Pharma Inc Unsponsored ADR Annual Profit & Loss
All numbers in Millions USD
Astellas Pharma Inc Unsponsored ADR Quarterly Cash Flow
All numbers in Millions USD
Astellas Pharma Inc Unsponsored ADR Annual Cash Flow
All numbers in Millions USD
Astellas Pharma Inc Unsponsored ADR News & Key Events
Insights on Astellas Pharma Inc Unsponsored ADR
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 5 quarters, 459.29B → 647.48B (in $), with an average increase of 8.2% per quarter
NO EFFECTAgainst Peers
In the last 1 year, AstraZeneca PLC has given 181.0% return, outperforming this stock by 142.5%
- NO EFFECT
Against Peers
In the last 3 years, AstraZeneca PLC has given 191.0% return, outperforming this stock by 197.9%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 102.13B → 57.96B (in $), with an average decrease of 43.2% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 months, ALPMY stock has moved down by -19.3%
About Astellas Pharma Inc Unsponsored ADR
| Organisation | Astellas Pharma Inc Unsponsored ADR |
| Headquarters | 2-5-1, Nihonbashi-Honcho, Chuo, Japan, 103-8411 |
| Industry | Drug Manufacturers - General |
| CEO | Mr. Katsuyoshi Sugita |
| E-voting on shares | Click here to vote |
Key Management of Astellas Pharma Inc Unsponsored ADR
Name | Title |
|---|---|
Mr. Nobuaki Tanaka | President of Japan Commercial & Senior Corporate Executive |
Ms. Leticia Delgado-Herrera | VP and Rx+ M&D Head |
Mr. Katsuyoshi Sugita | Executive VP, Chief People Officer & Representative Director |
Nobue Yasuda | General Manager of Finance & Accounting Department |
Mr. Yoshitsugu Shitaka Ph.D. | Chief Scientific Officer & Senior Managing Executive Officer |
Ms. Nobuko Kato | Chief Communications & Investor Relations Officer |
Ms. Tatjana Dragovic J.D. | General Counsel, Chief Ethics & Compliance Officer |
Jun Kono | Senior Executive Officer & Head of Japan Commercial |
Nori Kuwahara | Senior Vice President of Planning & Administration |
Salim Mujais | Senior VP & TA Head of Medical Specialties |
FAQs
What is Astellas Pharma Inc Unsponsored ADR share price today?
Astellas Pharma Inc Unsponsored ADR share price today is $13.29 as on at the close of the market. Astellas Pharma Inc Unsponsored ADR share today touched a day high of $13.41 and a low of $13.23.
What is the 52 week high and 52 week low for Astellas Pharma Inc Unsponsored ADR share?
Astellas Pharma Inc Unsponsored ADR share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Astellas Pharma Inc Unsponsored ADR stock price today i.e. is closed at $13.29,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.
What is Astellas Pharma Inc Unsponsored ADR's market capitalisation today?
Astellas Pharma Inc Unsponsored ADR market capitalisation is $0.02T as on .
How to invest in Astellas Pharma Inc Unsponsored ADR Stock (ALPMY) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Astellas Pharma Inc Unsponsored ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Astellas Pharma Inc Unsponsored ADR Shares that will get you 0.1129 shares as per Astellas Pharma Inc Unsponsored ADR share price of $13.29 per share as on July 3, 2026 at 1:28 am IST.
What is the minimum amount required to buy Astellas Pharma Inc Unsponsored ADR Stock (ALPMY) from India?
Indian investors can start investing in Astellas Pharma Inc Unsponsored ADR (ALPMY) shares with as little as ₹95.2 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Astellas Pharma Inc Unsponsored ADR stock (as per the Rupee-Dollar exchange rate as on ).
Based on Astellas Pharma Inc Unsponsored ADR share’s latest price of $13.29 as on July 3, 2026 at 1:28 am IST, you will get 0.7524 shares of Astellas Pharma Inc Unsponsored ADR. Learn more about
fractional shares .